International Financing Review (IFR)
VerifiedMagazine
In global capital markets, impeccable market intelligence lies at the heart of success. It informs and encourages excellent decision-making, which, in turn, breeds great performance. With a pedigree stretching back over four decades, IFR (International Financing Review) is the world’s leading provider of global capital markets intelligence. Source
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | Dutch, English |
| Country | United Kingdom |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Weekly |
| Days Published | Mon |
Recent Articles
Search ArticlesBlossomHill plants seed for Nasdaq IPO.
| BlossomHill Therapeutics filed for a US$100m Nasdaq IPO on Thursday. JP Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital and HC Wainright are joint bookrunners on an all-primary offering. The early-stage cancer specialist brings a macro approach to cancer innovation, with drugs that target entire spectrums of genetic mutations, not just specific protein malfunctions.
Swedfund set for ESG bonds
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Enpal solar ABS draws demand despite Moody's AAA holdout
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Bull market banking: Wall Street giants rake in profits
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Turkish IPO pipeline swells with approvals
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Bull market banking: US banking giants rake in profits
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
MDBs bulk up EM climate finance
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
SEC climate rollback gets muted public response
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Tailored Brands filing heralds Nasdaq return
| Tailored Brands filed for a Nasdaq IPO on July 10 that paves the way for the Men’s Wearhouse and Jos A Bank parent to return to the public market after having been forced to seek bankruptcy protection during the height of the Covid pandemic. Goldman Sachs, Morgan Stanley and Jefferies are joint bookrunners atop a syndicate of 10 banks leading the offering, which will comprise a mix of primary and secondary shares.
Regenxbio tops off with US$100m of equity
| Regenxbio padded its balance sheet late Thursday with US$100m from an overnight stock sale that helps derisk its plans to seek accelerated FDA approval for its muscular dystrophy drug. Morgan Stanley, JP Morgan, Leerink Partners and Mizuho Securities priced 11.1m shares at a US$9 fixed price, a hefty 19.6% discount to the $11.20 last sale. The offering was covered at launch by an earlier wall-crossing, including anchor-size orders from shareholders.